FDA ApprovedUnited States
New Daily Pill to Lower High ("Bad") Cholesterol
Lipfendra (enlicitide) — first oral PCSK9 inhibitor for high LDL-C in adults
The FDA labelled a once-daily 20 mg oral PCSK9 inhibitor tablet — take in the morning on an empty stomach — as an adjunct to diet and exercise to lower LDL-C…
Lipfendra (enlicitide) is a daily pill taken on an empty stomach. The United States approved it, with diet and exercise, to lower “bad” cholesterol in adults.